[Editor's note: This post is excerpted from this week's forthcoming NORML weekly media advisory. To have NORML's media alerts and legislative advisories delivered straight to your in-box, sign up here. To watch NORML's weekly video summary of the week's top stories, click here.] The administration of the synthetic cannabinoid agonist HU-211 decreases nerve cell death in [...]

More...